Kuang He
Chief Executive Officer at Zhejiang Chiral Medicine Chemicals Co., Ltd.
Profile
Kuang He has worked as an Analyst at Sofinnova Partners SAS since 2019.
He is also currently the General Manager at Zhejiang Chiral Medicine Chemicals Co., Ltd.
Kuang He active positions
Companies | Position | Start |
---|---|---|
Zhejiang Chiral Medicine Chemicals Co., Ltd.
Zhejiang Chiral Medicine Chemicals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Chiral Medicine Chemicals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates and raw materials. The company was founded on July 16, 2001 and is headquartered in Hangzhou, China. | Chief Executive Officer | - |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Analyst | 2019-11-30 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Zhejiang Chiral Medicine Chemicals Co., Ltd.
Zhejiang Chiral Medicine Chemicals Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Chiral Medicine Chemicals Co., Ltd. engages in the research, development, production, and sale of pharmaceutical intermediates and raw materials. The company was founded on July 16, 2001 and is headquartered in Hangzhou, China. | Health Technology |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
- Stock Market
- Insiders
- Kuang He